2025 bills / H.B. 519

H.B. 519 Health Care Access Amendments (2025)

Did not passWritten by Rep. Steve Eliason · carried in the Senate by Sen. Evan J. Vickers

  1. Introduced
  2. House committee
  3. House vote
  4. Senate committee (stopped here)
  5. Senate vote
  6. Signed into law

What this bill does

This bill would bar drug manufacturers from blocking or interfering with 340B entities, such as certain clinics and hospitals, when they buy discounted 340B drugs or take part in the federal 340B discount program. It would also let the Public Employees' Benefit and Insurance Program change its business practices to offset any financial effects.

Plain-English summary written by AI from the official description. Check the official text below.

Official description
  • defines a term
  • prohibits a pharmaceutical manufacturer from restricting, prohibiting, or otherwise interfering with a 340B entity's ability to:
  • acquire a 340B drug; or
  • participate in the 340B drug discount program
  • permits the Public Employees' Benefit and Insurance Program to adjust its business practices to mitigate any resulting financial impacts
Full text and history on le.utah.gov →

Your legislators on this bill

Enter your address to see what your own representative and senator did on this bill.

Take action

This bill's session is over, but your legislators still want to hear from you. Ideas that died often come back next year.

Enter your address to get your legislators' contact information and a ready-to-send message about this bill.

Follow H.B. 519

Members ($5 a month) get:

  • An alert the day H.B. 519 is put on a committee agenda, with time and room, so you can be there to speak
  • When H.B. 519 is rewritten, exactly which words changed
  • Its hearings in your own calendar
  • Your own scorecard: pick the side you favor and see how every legislator voted
Become a member

Or start free: A weekly email when H.B. 519 moves: hearings, votes, rewrites, signed or vetoed.

Every vote

Hearings and debates